Cytokinetics CYTK Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$829.61M-34.8% | -$784.96M-33.2% | -$751.94M-30.5% | -$606.31M-11.2% | -$615.26M-16.0% | ||
| $11.2M+17.9% | $10.13M+6.2% | $9.65M-28.5% | $9.38M-27.4% | $9.5M-23.2% | ||
| $119.13M+19.4% | $112.29M+14.8% | $108.03M+18.6% | $102.69M+21.6% | $99.78M+27.1% | ||
| -$523.85M-31.6% | -$510.01M-28.8% | -$432.93M-7.1% | -$426.92M-7.0% | -$398M+5.6% | ||
| $25.07M+162% | $24.81M+535% | $20.45M+659% | $11.8M+433% | $9.57M+844% | ||
| —— | —— | —— | —— | —— | ||
| —— | $729.46M— | $547.1M— | $364.73M— | $182.37M— | ||
| $10.86M+1.9% | $10.81M+24.5% | $10.76M+79.1% | $10.71M+220% | $10.66M+1,411% | ||
| $527.47M-36.6% | $524.46M-43.6% | $416.14M-62.1% | $89.1M-92.2% | $831.57M+150% | ||
| —— | —— | —— | —— | —— | ||
| -$548.92M-34.7% | -$534.82M-33.8% | -$453.38M-11.4% | -$438.72M-9.3% | -$407.57M+3.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytokinetics generate?
- Cytokinetics (CYTK) generated -$523.8M in operating cash flow over the trailing twelve months.
- What is Cytokinetics's free cash flow?
- After $25.1M of capital expenditures, Cytokinetics's free cash flow was -$548.9M over the trailing twelve months, down 34.7% year over year.
- Where does Cytokinetics's cash flow data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
